Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma

Subjects will be administered oral prednisolone at a dose of 0.5 mg/kg, up to a maximum of 40 mg per day for 14 days.

All subjects will undergo bronchoscopy assessments which will involve insertion of a standard bronchoscope.